Home・Stock List・AngioDynamics Inc

AngioDynamics Inc

Closed

SectorHealthcare

15.75 0.7

Buy Sell

Overview

Share price change

24h

Current

Min

15.59

Max

15.71

Key metrics
By Trading Economics
Income	-3.3M -11M
Sales	8.2M 87M
EPS	-0.07
Profit margin	-13.169
Employees	632
EBITDA	-26M -28M

Recommendations
By TipRanks
Recommendations	Strong Buy
12 Months Forecast	+33.84% upside

Dividends
By Acuity
Next Earnings	1 Oct 2026

Market Stats
By TradingEconomics
Market Cap	99M 627M
Previous open	15.05
Previous close	15.75

News Sentiment

By Acuity

50%

116 / 340 Healthcare

AngioDynamics Inc Chart

Past performance is not a reliable indicator of future results.

Related News

7 Aug 2026, 19:33 UTC

News

AngioDynamics shares are rising despite a downgrade to Q3 2028 earnings estimates. Analysts from Canaccord Genuity and HC Wainwright raised their price targets.

6 Aug 2026, 19:56 UTC

AngioDynamics shares are lower during Thursday's session, with no specific news identified. The stock remains above its 20-day moving average.

5 Aug 2026, 19:46 UTC

AngioDynamics Inc shares are lower amid broader market caution following ADP's report of only 44,000 private sector jobs added in July.

4 Aug 2026, 19:31 UTC

AngioDynamics Inc shares are lower today, driven by significant declines in the Health Care Equipment sub-sector. No specific company news was identified.

3 Aug 2026, 20:02 UTC

AngioDynamics Inc shares are higher today, supported by gains in the Health Care Equipment sector. The stock remains above its 20-day moving average.

31 Jul 2026, 19:33 UTC

AngioDynamics shares are lower amid broader market dynamics and rising bond yields, despite remaining above the 20-day moving average.

30 Jul 2026, 18:56 UTC

AngioDynamics Inc. shares are trading roughly flat, remaining above their 20-day moving average after four consecutive sessions of higher closes.

29 Jul 2026, 19:56 UTC

Macro Event

AngioDynamics Inc shares are higher since Tuesday, reflecting volatility from the Federal Reserve's interest rate decision and easing inflation data.

28 Jul 2026, 20:02 UTC

News

AngioDynamics will participate in two investor conferences this week, contributing to a notable increase in shares during Tuesday's session.

27 Jul 2026, 19:56 UTC

AngioDynamics Inc is rising amid strength in the health care equipment sector. The stock reached a peak earlier in the session before moderating gains.

24 Jul 2026, 18:36 UTC

AngioDynamics Inc is trading higher today, reflecting a positive market response. The stock remains above its 20-day moving average amid no specific news.

23 Jul 2026, 20:03 UTC

AngioDynamics Inc. shares are lower today, reflecting a decline from Wednesday's close amid broader market weakness in tech stocks related to rising AI capital expenditures.

22 Jul 2026, 19:56 UTC

AngioDynamics Inc shares are lower today, influenced by declines in the Health Care Equipment sub-sector. The stock remains above its 20-day moving average.

21 Jul 2026, 20:06 UTC

News

AngioDynamics Inc shares are higher today, supported by a strong Nasdaq 100 Index. Analysts maintain a Hold rating amid optimism for NanoKnife technology.

20 Jul 2026, 19:46 UTC

News

AngioDynamics shares are higher today, despite a downgrade to "strong sell" from Zacks Research and a price target increase from Canaccord Genuity to $20.00.

Peer Comparison

Price change

AngioDynamics Inc Forecast

Price Target

By TipRanks

33.84% upside

12 Months Forecast

Average 21 USD 33.84%

High 24 USD

Low 19 USD

Based on 3 Wall Street analysts offering 12 month price targets forAngioDynamics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

3 ratings

Buy

Hold

Sell

Based on 3 analysts giving stock ratings to AngioDynamics Inc - Dist in the past 3 months.

Sentiment

By Acuity

116 / 340 Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About AngioDynamics Inc

AngioDynamics, Inc., a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium. Its thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit, indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. The company also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures. In addition, it provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-Access kits provides interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero MTA System includes solero microwave generator and the specially designed solero MW applicators. The company was founded in 1988 and is headquartered in Latham, New York.